10 Einträge gefunden

1. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510

   1. Högner, Anica
   2. Al-Batran, Salah-Eddin
   3. Siveke, Jens T
   4. Lorenz, Mario
   5. Bartels, Prisca
   6. Breithaupt, Kirstin
   7. Malfertheiner, Peter

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer

   1. Kripp, Melanie
   2. Prasnikar, Nicole
   3. Vehling-Kaiser, Ursula
   4. Quidde, Julia
   5. Al-Batran, Salah-Eddin
   6. Stein, Alexander
   7. Neben, Kai

   2017 - Forschungsinformationssystem des UKE
3. Multimodale Therapie des lokalisierten Magenkarzinoms

   1. Stein, Alexander
   2. Arnold, Dirk
   3. Al-Batran, Salah-Eddin

   2016 - Forschungsinformationssystem des UKE
4. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

   1. Hegewisch-Becker, Susanna
   2. Graeven, Ullrich
   3. Lerchenmüller, Christian A
   4. Killing, Birgitta
   5. Depenbusch, Reinhard
   6. Steffens, Claus-Christoph
   7. Al-Batran, Salah-Eddin

   2015 - Forschungsinformationssystem des UKE
5. The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).

   1. Al-Batran, Salah-Eddin
   2. Pauligk, Claudia
   3. Homann, Nils
   4. Hartmann, Jörg T
   5. Moehler, Markus
   6. Probst, Stephan
   7. Rethwisch, Volker

   2013 - Forschungsinformationssystem des UKE
6. Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature

   1. Stein, Alexander
   2. Peinert, Stefan
   3. Al-Batran, Salah-Eddin
   4. Arnold, Dirk

   2012 - Forschungsinformationssystem des UKE
7. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

   1. Goekkurt, Eray
   2. Al-Batran, Salah-Eddin
   3. Hartmann, Jörg T
   4. Mogck, Ulrike
   5. Schuch, Gunter
   6. Kramer, Michael
   7. Jaeger, Elke

   2009 - Forschungsinformationssystem des UKE
8. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

   1. Al-Batran, Salah-Eddin
   2. Hartmann, Joerg Thomas
   3. Probst, Stephan
   4. Schmalenberg, Harald
   5. Hollerbach, Stephan
   6. Hofheinz, Ralf
   7. Rethwisch, Volker

   2008 - Forschungsinformationssystem des UKE
9. Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.

   1. Al-Batran, Salah-Eddin
   2. Hartmann, Joerg Thomas
   3. Heidel, Florian
   4. Stoehlmacher, Jan
   5. Wardelmann, Eva
   6. Dechow, Claudius
   7. Düx, Markus

   2007 - Forschungsinformationssystem des UKE
10. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.

    1. Hartmann, Jörg Thomas
    2. Pintoffl, Jan Peter
    3. Al-Batran, Salah-Eddin
    4. Quietzsch, Detlef
    5. Meisinger, Ines
    6. Horger, Marius
    7. Nehls, Oliver

    2007 - Forschungsinformationssystem des UKE